FTT 0.00% 0.5¢ factor therapeutics limited

A Question never answered by this Board

  1. 312 Posts.
    lightbulb Created with Sketch. 90
    Based on management statements, we all know that the clinical trial failed because the standard of care performed too well compared to our bullshit technology.

    Now, and this is a strong hint how badly we have been played on the general assumption that we are so stupid,, based on which ground the wound healing technology has been considered useless for repairing the eye wounds (a market valued at more than $1.5 billion and with not an existing cure)?

    The reason is that the technology is sheet as a whole.
    $70 millions wasted in the toilet on a story that was fabricated to last for years to squeeze our pocket.

    Otherwise, the cornea repairing technology would have been emphasized and brought forward, if there was a sense in all what it was said to us.

    isn't true?
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.